Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8537315 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2018 | 48 Pages |
Abstract
Mice subjected to conditioned naloxone-induced morphine withdrawal robustly expressed CPA. Pre-treatment with the selective CRF1R antagonist CP-154,526 before naloxone conditioning session impaired morphine withdrawal-induced aversive memory acquisition. CP-154,526 also antagonized the enhanced number of TH-positive neurons in the NTS-A2 that was seen after CPA. Increased Arc expression and Arc-pCREB co-localization were seen in the BLA after CPA, which was not modified by CP-154,526. In the DG, CPA was accompanied by a decrease of Arc expression and no changes in Arc-pCREB co-localization, whereas pre-treatment with CP-154,526 induced an increase in both parameters. These results indicate that CRF-CRF1R pathway could be a critical factor governing opiate withdrawal memory storage and retrieval and might suggest a role for TH-NA pathway in the effects of withdrawal on memory. Our results might indicate that the blockade of CRF1R could represent a promising pharmacological treatment strategy approach for the attenuation of the relapse to drug-seeking/taking behavior triggered by opiate withdrawal-associated aversive memories.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
E. Valero, I. Gómez-Milanés, P. Almela, B. Ribeiro Do Couto, M.L. Laorden, M.V. Milanés, C. Núñez,